EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases

Lydia J Bye, Rocio K Finol-Urdaneta, Han-Shen Tae, David J Adams

The International Journal of Biochemistry & Cell Biology · 2023

DOI: 10.1016/j.biocel.2023.106387 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2023. Verfasst von Lydia J Bye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Illawarra Health and Medical Research Institute (IHMRI), Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522 Australia. Hauptthemen laut MEDLINE: Receptors, Nicotinic, Neurodegenerative Diseases, Parkinson Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 170 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinic acetylcholine receptors (nAChRs) are master regulators of immune functions via the cholinergic anti-inflammatory pathway and are expressed in microglia, the brain's resident immune cells. There is an extensive dialogue between the neurons and the glial cells around them from which microglia are tasked with monitoring, nurturing, and defending their microenvironment. Dysregulation of any of these processes can have devastating and long-lasting consequences involving microglia-mediated neuroinflammation associated with neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, amongst others. Disease-associated microglia acquire a distinguishing phenotype that emphasizes scavenging and defence functions while nurturing and repairing functions become muted. Attempts to resolve this critical imbalance remain a key focus of research. Furthermore, cholinergic modulation of neuroinflammation represents a promising avenue for treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, NicotinicNeurodegenerative DiseasesParkinson DiseaseHumansNeuroinflammatory DiseasesCholinergic AgentsMicrogliaInflammation

Stichwörter der Autor:innen

InflammationMicrogliaNeurodegenerative diseasesNeuroinflammationNicotinic acetylcholine receptor

Substanzen

Receptors, NicotinicCholinergic Agents

Autor:innen und Institutionen

  • Illawarra Health and Medical Research Institute (IHMRI), Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522 Australia.
  • Illawarra Health and Medical Research Institute (IHMRI), Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522 Australia. Electronic address: djadams@uow.edu.au.

Zitieren

APA

Bye, L. J., Finol-Urdaneta, R. K., Tae, H. S., & Adams, D. J. (2023). Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2023.106387

Vancouver

Bye LJ, Finol-Urdaneta RK, Tae HS, Adams DJ. Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases. The International Journal of Biochemistry & Cell Biology. 2023. doi:10.1016/j.biocel.2023.106387

BibTeX
@article{Bye2023,
  author = {Bye, Lydia J and Finol-Urdaneta, Rocio K and Tae, Han-Shen and Adams, David J},
  title = {Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2023},
  doi = {10.1016/j.biocel.2023.106387}
}
Kostenlos starten →